TD Waterhouse Canada’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168M Buy
176,351
+82,725
+88% +$83.9M 0.5% 42
2025
Q4
$101M Buy
93,626
+5,311
+6% +$5.08M 0.63% 34
2025
Q3
$73M Buy
88,315
+3,578
+4% +$2.66M 0.48% 46
2025
Q2
$65.8M Buy
84,737
+3,899
+5% +$3.03M 0.47% 51
2025
Q1
$65.1M Sell
80,838
-34
-0% -$28.3K 0.53% 41
2024
Q4
$62.5M Sell
80,872
-5,678
-7% -$4.7M 0.5% 45
2024
Q3
$76.4M Buy
86,550
+7,221
+9% +$6.49M 0.62% 41
2024
Q2
$72.6M Buy
79,329
+7,262
+10% +$5.81M 0.65% 38
2024
Q1
$60.3M Sell
72,067
-3,707
-5% -$2.64M 0.45% 45
2023
Q4
$49.9M Buy
75,774
+10,437
+16% +$6.09M 0.47% 44
2023
Q3
$39M Buy
65,337
+7,057
+12% +$3.64M 0.41% 52
2023
Q2
$29.7M Sell
58,280
-13,138
-18% -$5.51M 0.3% 64
2023
Q1
$28.9M Sell
71,418
-6,973
-9% -$2.35M 0.3% 62
2022
Q4
$33.5M Buy
78,391
+14,538
+23% +$5.15M 0.37% 51
2022
Q3
$22.9M Sell
63,853
-13,225
-17% -$4.19M 0.26% 70
2022
Q2
$28M Buy
77,078
+8,541
+12% +$2.56M 0.32% 64
2022
Q1
$21.8M Sell
68,537
-28,809
-30% -$7.41M 0.21% 85
2021
Q4
$27.8M Buy
+97,346
New +$24.7M 0.27% 72

Other funds holding LLY

TD Waterhouse Canada's LLY Position: Q1 2026 in Review

TD Waterhouse Canada increased its Eli Lilly (LLY) stake by 88% in Q1 2026, buying an estimated $83.9M and bringing the position to 176,351 shares worth $168M. The position accounts for 0.5% of the portfolio, ranked #42.

TD Waterhouse Canada first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TD Waterhouse Canada held 176,351 shares of Eli Lilly worth $168M as of Q1 2026.
  • TD Waterhouse Canada bought 82,725 Eli Lilly shares in Q1 2026, an estimated $83.9M.
  • Eli Lilly made up 0.5% of TD Waterhouse Canada's portfolio in Q1 2026, its #42 holding.
  • TD Waterhouse Canada first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.